EXHIBIT 10.21
STOCK AND WARRANT PURCHASE
AGREEMENT
THIS STOCK AND WARRANT PURCHASE
AGREEMENT (this “Agreement”) is made on the 28th day of
August, 2008, by and among BALQON CORPORATION, a California
corporation (the “Company”), and MARLIN FINANCIAL
GROUP, INC. (the “Investor”).
THE PARTIES HEREBY AGREE AS
FOLLOWS:
1. Purchase and Sale of Stock and
Warrants
1.1 Sale and Issuance of Stock and
Warrants
(a) Subject to the terms and conditions of this
Agreement, the Investor agrees to purchase at the Closing, and the
Company agrees to sell and issue to the Investor at the Closing,
Two Million Nine Hundred Sixteen Thousand Seven Hundred Twenty-Five
(2,916,725) shares (the “Issue Shares”) of the no par
value common stock of the Company (the “Common
Stock”).
(b) Subject to the terms and conditions of this
Agreement, the Investor agrees to purchase at the Closing, and the
Company agrees to sell and issue to the Investor at the Closing,
warrants to purchase up to Seven Hundred Twenty-Nine Thousand One
Hundred Eighty (729,180) shares of the Common Stock (the
“Warrants;” collectively with the Issue Shares and the
Warrant Shares, as defined in section 1.3 of the Agreement, the
“Shares”) on the terms and conditions set forth in this
Agreement.
(c) As consideration for the Issue Shares and
the Warrants, and in exchange therefor, (i) Investor has, pursuant
to an oral agreement, provided valuable services to the Company the
monetary value of which the board of directors of the Company has
determined to be Fifty-Five Thousand and No/100 Dollars
($55,000.00) (the “Services Purchase Price”); and (ii)
Investor shall pay to the Company Eight Hundred Seventy-Five and
No/100 Dollars ($875.00) (the “Cash Purchase Price;”
collectively with the Services Purchase Price, the “Purchase
Price”). The total aggregate value of the Purchase Price
shall be Fifty-Five Thousand Eight Hundred Seventy-Five and No/100
Dollars ($55,875.00).
(d) The parties acknowledge that the appraised
value of the Shares is approximately $42,438.00 and Investor agrees
that upon receipt of the Shares, Investor shall be paid in full for
the services rendered to the Company and referenced in section 1(c)
above, and Investor shall have no further claim for any additional
payment therefor.
1.2 Closing . The purchase and sale of
the Issue Shares and the Warrants shall take place at the offices
of the Company at 11:00 A.M., on August__, 2008, or at such other
time and place as the Company and the Investor mutually agree upon
orally or in writing (which time and place are designated as the
“Closing”). At the Closing, the Company shall deliver
to Investor a duly executed stock certificate representing the
Issue Shares and the duly executed Warrants and Investor shall
deliver to the Company the Cash Purchase Price and all other
documents and materials required pursuant to this Agreement.
Notwithstanding any other provision of this Agreement to the
contrary, in no event shall the Company be required to issue any
Issue Shares or Warrants to Investor unless and until all payments
and other documents and materials required to be delivered by
Investor have been received by the Company and all conditions of
this Agreement have been fulfilled.
1.3 Warrants and Warrant Shares .
Investor may exercise its right to purchase shares of the Common
Stock, pursuant to the Warrants, on the terms and conditions set
forth in this section (the “Warrant
Shares”).
(a) No later than one (1) year after the date of
registration with the SEC of any shares of the Common Stock of the
Company for sale or resale to the public (“First Termination
Date”), Investor may elect to purchase, whereupon the Company
shall issue, pursuant to the terms and conditions of this
Agreement, up to Two Hundred Forty-Three Thousand Sixty (243,060)
Warrant Shares at an exercise price of One and 50/100 Dollars
($1.50) per share (“First Exercise Price”).
Investor’s right to purchase any Warrant Shares pursuant to
this subsection shall expire at 5:00 P.M. Pacific Time on the First
Termination Date.
(b) No later than two (2) years after the date
of such registration of any shares of the Common Stock of the
Company (“Second Termination Date”), Investor may elect
to purchase, whereupon the Company shall issue, pursuant to the
terms and conditions of this Agreement, up to Two Hundred
Forty-Three Thousand Sixty (243,060) Warrant Shares at an exercise
price of Two and No/100 Dollars ($2.00) per share (“Second
Exercise Price”). Investor’s right to purchase any
Warrant Shares pursuant to this subsection shall expire at 5:00
P.M. Pacific Time on the Second Termination Date.
(c) No later than three (3) years after the date
of such registration of any shares of the Common Stock of the
Company (“Third Termination Date;” collectively with
the First Termination Date and the Second Termination Date, the
“Termination Dates”), Investor may elect to purchase,
whereupon the Company shall issue, pursuant to the terms and
conditions of this Agreement, up to Two Hundred Forty-Three
Thousand Sixty (243,060) Warrant Shares at an exercise price of Two
and 50/100 Dollars ($2.50) per share (“Third Exercise
Price;” collectively with the First Exercise Price and the
Second Exercise Price, the “Exercise Price”).
Investor’s right to purchase any Warrant Shares pursuant to
this subsection shall expire at 5:00 P.M. Pacific Time on the Third
Termination Date.
(d) Notwithstanding any other provision of this
Agreement to the contrary, in no event shall Investor be permitted
to purchase any Warrant Shares later than the date which is ten
(10) years after the date of this Agreement, nor shall any Warrant
be sold, transferred, assigned, hypothecated, pledged, or in any
way alienated (each a “Transfer”) by Investor to any
person and all such attempted or purported Transfers shall be null
and void.
(e) In order to exercise any right to purchase
Warrant Shares, Investor shall deliver to the Company written and
executed notice of Investor’s intent to exercise
Investor’s right to purchase said Warrant Shares (the
“Notice”). The Notice shall specify the number of
Warrant Shares which Investor elects to purchase, the applicable
Exercise Price per share, and the total price for all Warrant
Shares which Investor intends to purchase. Unless the Notice is
delivered before 5:00 P.M. Pacific Time on the applicable
Termination Date, the Notice shall be null and void.
(f) If the Notice is timely delivered to the
Company, the purchase and sale of the Warrant Shares shall take
place at the offices of the Company at 11:00 A.M., on the day which
is ten (10) business days after the timely delivery of the Notice
to the Company, or at such other time and place as the Company and
the Investor mutually agree upon orally or in writing (each such
time and place are designated as a “Warrant Closing”).
At each Warrant Closing, the Company shall deliver to Investor a
duly executed stock certificate representing the Warrant Shares
that Investor is purchasing and Investor shall deliver to the
Company the applicable Exercise Price and all other, documents and
materials required pursuant to this Agreement. Notwithstanding any
other provision of this Agreement to the contrary, in no event
shall the Company be required to issue any Warrant Shares to
Investor unless and until (i) such issuance is in compliance with
all applicable federal and state securities laws, and (ii) all
payments and other documents and materials required to be delivered
by Investor have been received by the Company and all conditions of
this Agreement have been fulfilled.
2. Representations and Warranties of the
Company . The Company hereby represents and warrants to
Investor that, as of the date hereof unless a different date is
specified, and except as set forth on a Schedule of Exceptions (the
“Schedule of Exceptions”) furnished to the Investor
prior to execution hereof and attached hereto as Schedule A,
which exceptions shall be deemed to be representations and
warranties as if made hereunder:
2.1 Organization. Good Standing and
Qualification . The Company is a corporation duly organized,
validly existing and in good standing under the laws of the State
of California. The Company is duly qualified to transact business
and is in good standing in each jurisdiction in which the failure
to so qualify would have a material adverse effect on its business
or properties.
2.2 Capitalization Common Stock . The
authorized capital of the Company consists of One Hundred Million
(100,000,000) shares of common stock, no par value per share, of
which Sixteen Million Six Hundred Sixty-Seven Thousand (16,667,000)
shares are issued and outstanding as of the date hereof.
(b) As of the date hereof, the outstanding
shares of Common Stock are owned by the stockholders and in the
numbers specified in Exhibit A hereto.
(c) The outstanding shares of Common Stock are
all duly and validly authorized and issued, fully paid and
nonassessable, and were issued in compliance with all applicable
state and federal laws concerning the issuance of
securities.
(d) Except as set forth in the Schedule of
Exceptions attached hereto as Schedule A , there are not
outstanding any options, warrants, rights (including conversion or
preemptive rights) or agreements for the purchase or acquisition
from the Company of any shares of its capital stock. Except as set
forth herein, the Company is not a party or subject to any
agreement or understanding, and, to the Company’s knowledge,
there is no agreement or understanding between any persons and/or
entities, which affects or relates to the voting or giving of
written consents with respect to any security or by a director of
the Company.
2.3 Subsidiaries . The Company does not
presently own or control, directly or indirectly, any interest in
any other corporation, association, or other business entity. The
Company is not a participant in any joint venture, partnership, or
similar arrangement.
2.4 Authorization . All corporate action
on the part of the Company, its officers, directors and
stockholders necessary for the authorization, execution and
delivery of this Agreement and the performance of all obligations
of the Company hereunder has been taken. This Agreement constitutes
valid and legally binding obligations of the Company, enforceable
in accordance with its terms, except (i) as limited by applicable
bankruptcy, insolvency, reorganization, moratorium and other laws
of general application affecting enforcement of creditors’
rights generally, and (ii) as limited by laws relating to the
availability of specific performance, injunctive relief or other
equitable remedies.
2.5 Valid Issuance of Common Stock . The
Common Stock that is being purchased by the Investor hereunder,
when issued, sold and delivered in accordance with the terms of
this Agreement for the consideration expressed herein, will be duly
and validly issued, fully paid and nonassessable and will be free
of restrictions on transfer, other than restrictions on transfer
under this Agreement and under applicable state and federal
securities laws.
2.6 Governmental Consents . No consent,
approval, order or authorization of, or registration,
qualification, designation, declaration or filing with, any
federal, state or local governmental authority on the part of the
Company is required in connection with the issuance of the Issue
Shares and Warrants, except for such filings as are required
pursuant to applicable federal and state securities laws and blue
sky laws, which filings will be effected within the required
statutory period.
2.7 Offering . Subject in part to the
truth and accuracy of the Investor’s representations set
forth in Section 3 of this Agreement, the offer, sale and issuance
of the Shares as contemplated by this Agreement are exempt from the
registration requirements of the Securities Act of 1933, as amended
(the “Act”), and the qualification or registration
requirements of applicable blue sky laws. Neither the Company nor
any authorized agent acting on its behalf will take any action
hereafter that would cause the loss of such exemptions.
2.8 Litigation . There is no action,
suit, proceeding or investigation pending, or to the
Company’s knowledge, currently threatened against the Company
that questions the validity of this Agreement or the right of the
Company to enter into such agreement or to consummate the
transactions contemplated hereby, or that might result, either
individually or in the aggregate, in any material adverse changes
in the business, assets or condition of the Company, financially or
otherwise, or any change in the current equity ownership of the
Company. The Company is not a party or subject to the provisions of
any order, writ, injunction, judgment or decree of any court or
government agency or instrumentality. There is no action, suit,
proceeding or investigation by the. Company currently pending or
that the Company intends to initiate.
2.9 Compliance with Other Instruments .
The Company is not in violation in any material respect of any
provision of its articles of incorporation (the
“Articles”) or bylaws (the “Bylaws”) nor,
to its knowledge, in any material respect of any instrument,
judgment, order, writ, decree or contract, statute, rule or
regulation to which the Company is subject and a violation of which
would have a material adverse effect on the condition, financial or
otherwise, or operations of the Company. The execution, delivery
and performance of this Agreement and the consummation of the
transactions contem
|